MM Pharma & Healthcare Packaging is a market leader in Europe and the US with an attractive position in GLP-1-Analoga (e.g. against diabetes or obesity).
MM Pharma & Healthcare Packaging
MM offers centres on secondary packaging solutions from a global production network, including folding cartons, leaflets, and labels.
Share in Group Sales
Values Q3 2025 (LTM)
Share in Group adjusted EBITDA
Values Q3 2025 (LTM)
Highly Specialised Offer
The international network of 25 sites in Europe and America supplies around 80% of the largest pharmaceutical companies as well as CMOs (Contract Manufacturing Organisations) and a large number of mid-sized pharmaceutical companies.
Pharma customers expect outstanding supply reliability and flexibility to support their future growth. MM is uniquely positioned to meet these requirements with its global and scalable packaging production network and the benefits of MM Board & Paper’s compelling virgin fibre-based cartonboard specifically for pharmaceutical applications.
In addition, we offer our customers tailor-made services through local capacities, such as the improvement of processes in their packaging lines and the optimisation of supply chain processes.
As a market leader, we strive to provide our customers with leading innovations in the areas that matter most to them, such as patient safety and sustainability.
Sales by destination (Values 2024)
More about MM Pharma & Healthcare Packaging
If you are interested in the products and applications, go MM Pharma & Healthcare Packaging to find out more.
Investors
Get in contact with Investor Relations
We look forward to your message and always seek a prompt answer.
IR News
Publication Mailing
To keep you regularly updated about company reports and press releases, we offer the options of subscription to our publication mailing for shareholders and stakeholders.